Clinical Trials
40 trialsNCT05219162 2025-09-11
GPS
AstraZeneca
Phase 4 Completed
NCT03715205 2025-08-29
Keynote-593
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT03285763 2025-01-23
TAIL
Hoffmann-La Roche
Phase 4 Completed
NCT04078152 2024-12-20
WAVE
AstraZeneca
Phase 4 Completed
NCT04541706 2024-12-20
Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India
Pfizer
Phase 4 Completed
NCT03672643 2024-11-08
Long Term Safety Observation of Crizotinib in Chinese NSCLC Population
Pfizer
Phase 4 Terminated
NCT04416633 2024-11-08
Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC
AstraZeneca
Phase 4 Completed
NCT04511533 2024-04-05
Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations
Pfizer
Phase 4 Completed
NCT04792970 2023-09-28
Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
Duke University
Phase 4 Terminated
NCT04381494 2023-06-22
ON TRAX
AstraZeneca
Phase 4 Terminated
NCT02869789 2023-06-15
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Bristol-Myers Squibb
Phase 4 Completed
NCT04155008 2022-11-16
Nutrition and Pharmacological Algorithm for Oncology Patients Study
Montefiore Medical Center
Phase 4 Terminated
NCT03853551 2021-06-03
Osimertinib Study in Indian Patients
AstraZeneca
Phase 4 Completed
NCT03444766 2020-12-04
Study of Nivolumab for Advanced Cancers in India
Bristol-Myers Squibb
Phase 4 Completed
NCT03642457 2020-09-30
Efficacy Between Serratus Plane Block And Local Infiltration In Vats
Icahn School of Medicine at Mount Sinai
Phase 4 Terminated
NCT02514174 2020-03-30
Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older
Boehringer Ingelheim
Phase 4 Completed
NCT02623959 2019-08-07
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02208843 2018-12-17
Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation
Boehringer Ingelheim
Phase 4 Completed
NCT02151149 2018-09-24
ABOUND 70+
Celgene
Phase 4 Completed
NCT00455923 2018-02-05
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
Phase 4 Completed
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT02695290 2017-09-18
Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
Boehringer Ingelheim
Phase 4 Terminated
NCT01783236 2017-05-11
Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery
Weill Medical College of Cornell University
Phase 4 Completed
NCT01203917 2017-01-02
IFUM
AstraZeneca
Phase 4 Completed
NCT00949910 2016-10-05
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche
Phase 4 Completed
NCT00451906 2016-05-24
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Hoffmann-La Roche
Phase 4 Completed
NCT01317615 2016-03-30
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Novartis
Phase 4 Completed
NCT00365508 2016-03-29
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Fox Chase Cancer Center
Phase 4 Completed
NCT00770588 2016-02-08
INFORM
AstraZeneca
Phase 4 Completed
NCT01609543 2016-02-01
A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations
Hoffmann-La Roche
Phase 4 Completed
NCT02000531 2016-01-13
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population
Hoffmann-La Roche
Phase 4 Completed
NCT01196078 2015-07-27
A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00747916 2015-07-16
Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")
CSA Medical, Inc.
Phase 4 Terminated
NCT01287754 2015-06-02
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations
Hoffmann-La Roche
Phase 4 Completed
NCT01230710 2015-03-30
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression
Hoffmann-La Roche
Phase 4 Completed
NCT00883675 2013-12-18
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Maestro Clinical, Inc.
Phase 4 Completed
NCT00536107 2013-10-01
Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
AstraZeneca
Phase 4 Terminated
NCT01020786 2013-08-27
A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients
Eli Lilly and Company
Phase 4 Completed
NCT00608868 2012-09-28
SELINE
AstraZeneca
Phase 4 Completed
NCT00380718 2010-11-16
Chemotherapy for Patients With Non-Small Cell Lung Cancer
Eli Lilly and Company
Phase 4 Completed